What is Samara Capital's investment strategy?
Samara Capital is covered in Rupeia's private equity research universe. The current public record describes the strategy as Buyout, with a sector focus of Consumer, retail, health. The profile should be read with the linked source trail and Typical route: Category II AIF context.
What portfolio evidence is available for Samara Capital?
The profile displays only company or asset names attributable to Samara Capital in the reviewed public sources: More Retail, Paradise Biryani, Sapphire Foods, Sundrop Brands, Marengo Asia Healthcare, Sahajanand Medical Technologies, Sekhmet Pharmaventures, First Meridian Group, SMS Integrated Facility Services. It does not represent a complete current portfolio unless the manager has published one.
What is known about Samara Capital's performance or track record?
Samara states that Fund II completed ten investments with positive returns across the portfolio, generated more than ₹7,500 Cr in value and delivered approximately 25% gross IRR on an investment base above ₹3,000 Cr. These are manager-reported gross outcomes, not net LP returns. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
What are Samara Capital's fund size, fees and minimum investment?
Public fund size: Samara’s public materials identify Fund II and other vehicles but do not provide a current consolidated AUM figure for India.. Public terms or access information: Control and growth-oriented investments in mid-market companies, with operating support and downside protection; current cheque and reserve ranges are not uniformly disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
Who is on Samara Capital's investment team?
The current source record names Sumeet Narang. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
What risks should be reviewed before investing with Samara Capital?
Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: Fund III final size, vehicle-level deployment and net returns are not publicly disclosed; the manager’s public site provides attributable portfolio and exit evidence..
What is the latest public update on Samara Capital?
2026-09-21: Samara’s current platform page identifies a live India mid-market PE portfolio across consumer, healthcare, financial services and business services. The manager announced the final Fund II exit through the February 2026 SMS Integrated Facility Services sale and reported a 25% IRR across Fund II investments; it also disclosed a 2026 logistics-platform acquisition involving Associated Road Carriers and Calyx Container Terminals.